Italia markets closed

Exelixis, Inc. (0IJO.L)

LSE - LSE Prezzo differito. Valuta in USD.
Aggiungi a watchlist
19,01+0,44 (+2,36%)
Alla chiusura: 04:18PM BST
Schermo intero
Chiusura precedente18,57
Denaro0,00 x N/D
Lettera0,00 x N/D
Min-Max giorno19,01 - 19,01
Intervallo di 52 settimane19,01 - 19,01
Media VolumeN/D
Beta (5 anni mensile)0,69
Rapporto PE (ttm)0,21
EPS (ttm)0,92
Prossima data utili02 mag 2023 - 08 mag 2023
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendoN/D
Stima target 1AN/D
  • GlobeNewswire

    Phathom Pharmaceuticals Appoints Frank Karbe to its Board of Directors

    FLORHAM PARK, N.J., April 26, 2022 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, today announced the appointment of Frank Karbe to its Board of Directors. Mr. Karbe, who most recently served as President and Chief Financial Officer of Myovant Sciences, Inc. (NYSE:MYOV), brings over twenty-five years of financial and life-sciences expertise to Phathom. “We are